Interestingly, induction of Fgf15 expression in mice by intestinal Fxr overexpression protects against cholestasis and fibrosis, along with a reduction of the BA pool size25 suggesting that modulation of FGF19 levels could offer benefits in a plethora of BA-related metabolic disorders. This evidence concerns the gene NR1H4 and cholestasis.